Crimson - i2b2 integration for high-throughput, scalable sample collection

Crimson - i2b2 集成，用于高通量、可扩展的样本收集

• 批准号: 7918185
• 负责人: LYNN BRY
• 金额: $ 44.5万
• 依托单位: BRIGHAM AND WOMEN'S HOSPITAL
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-09-01 至 2012-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7918185
• 关键词: Academic Medical Centers; Address; Area; Automobile Driving; Biology; Biomedical Research; Cells; Clinical; Clinical Data; Collection; Communication; Consent; Cost Savings; Country; DNA analysis; Dana-Farber Cancer Institute; Data; Data Set; Economic Models; Effectiveness; General Hospitals; Genomics; Goals; Hospitals; Human; Informatics; Institution; Investments; Laboratories; Link; Manuals; Massachusetts; Methods; Modeling; Ontology; Pathology; Phenotype; Process; Proteins; Research; Research Ethics Committees; Research Infrastructure; Research Personnel; Research Support; Resources; Sampling; Site; Solutions; Stream; Testing; Time; Urticaria; Validation; Vocabulary; Woman; base; clinical data warehouse; clinical phenotype; cohort; cost; cost effective; design; discount; interoperability; open source; operation; prospective; research study; sample collection; tool

DESCRIPTION (provided by applicant): Lack of well-phenotype samples remains a key bottleneck in biomedical research. The costs associated with collection often exceed those associated with any other step in the discovery process. The Crimson application addresses these issues by enabling high-throughput, cost-effective collection of samples for IRB-approved studies by (1) real-time query of discarded samples from Clinical Laboratories and (2) leveraging cohorts generated with i2b2's tools (Informatics for Integrating Biology to the Bedside). Crimson's use with i2b2 has significantly reduced costs associated with sample collection for investigators, often by 1-2 orders of magnitude, while also increasing the throughput of materials available to IRB-approved studies. We believe full integration of Crimson as an i2b2 cell will further promulgate these capabilities at both local and national levels. We propose to develop Crimson vocabularies to increase its interoperability within the i2b2 infrastructure, further design and develop means for distributed queries enabling high-throughput sample collection across institutions, and develop and test an economic model of Crimson's impact upon a research enterprise for studies using Crimson within i2b2 to enable high-throughput sample collection for large-scale research studies.

描述（由申请人提供）： 缺乏良好表型样本仍然是生物医学研究的一个关键瓶颈。与收集相关的成本通常超过与发现过程中任何其他步骤相关的成本。 Crimson 应用程序通过 (1) 实时查询临床实验室废弃样本以及 (2) 利用 i2b2 工具（Informatics for将生物学整合到床边）。 Crimson 与 i2b2 的使用显着降低了研究人员与样本收集相关的成本，通常降低了 1-2 个数量级，同时还提高了 IRB 批准的研究可用材料的吞吐量。我们相信，Crimson 作为 i2b2 单元的全面集成将在地方和国家层面进一步推广这些功能。我们建议开发 Crimson 词汇表以提高其在 i2b2 基础设施内的互操作性，进一步设计和开发分布式查询的方法，以实现跨机构的高通量样本收集，并开发和测试 Crimson 对研究企业影响的经济模型，以便使用 Crimson 进行研究i2b2 内支持大规模研究的高通量样本收集。